Patients in the CA group showed a higher incidence of heart-related symptoms and related blood test indicators, such as increased NT-proBNP and Troponin T levels, indicating the severity of cardiac involvement in amyloidosis. The gene discussed is NPPB; the disease is amyloidosis.